UMIN-CTR History

Name:  UMIN ID:


Unique ID issued by UMIN UMIN000024528
Receipt number R000028208
Scientific Title First-line single-agent Panitumumab in the Japanese frail patients with wild-type RAS unresectable colorectal cancer: A phase II study(OGSG 1602)
Date of disclosure of the study information 2016/12/01
Last modified on 2022/09/25 22:30:06

No. Disposal Last modified on Item of update
1 Insert 2016/10/23 23:17:47
2 Update 2017/05/31 21:14:48 Recruitment status
3 Update 2017/07/16 17:35:08 Key inclusion criteria
Key inclusion criteria
4 Update 2017/10/02 23:30:03 Last follow-up date
5 Update 2017/10/26 20:28:43 Email
6 Update 2018/04/26 23:24:35 Institutions
7 Update 2018/08/01 06:47:30 UMIN ID1
8 Update 2018/08/03 18:40:26 Recruitment status
Anticipated trial start date
Last follow-up date
9 Update 2018/08/19 21:01:42 Last follow-up date
10 Update 2018/10/25 23:06:47 Last follow-up date
11 Update 2019/10/30 22:38:05 URL releasing protocol
Number of participants that the trial has enrolled
12 Update 2020/01/05 21:29:56 Date of IRB
13 Update 2020/11/02 07:17:13 Recruitment status
Date analysis concluded
14 Update 2020/11/24 14:34:17 Publication of results
Results
Results
Results date posted
Date of the first journal publication of results
15 Update 2020/11/24 14:38:13 Recruitment status
16 Update 2022/09/25 22:29:05 URL related to results and publications
Results
Results
Baseline Characteristics
Baseline Characteristics
Participant flow
Participant flow
Adverse events
Adverse events
Outcome measures
Outcome measures
17 Update 2022/09/25 22:30:06 Publication of results